{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["ESKAPE pathogens", "SEM", "antimicrobial activity", "antimicrobial resistance", "ozone", "pathogenic bacteria"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "35807244", "DateCompleted": {"Year": "2022", "Month": "07", "Day": "12"}, "DateRevised": {"Year": "2023", "Month": "11", "Day": "05"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2022", "Month": "06", "Day": "22"}], "ELocationID": ["3998", "10.3390/molecules27133998"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "27", "Issue": "13", "PubDate": {"Year": "2022", "Month": "Jun", "Day": "22"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Potent Activity of a High Concentration of Chemical Ozone against Antibiotic-Resistant Bacteria.", "Abstract": {"AbstractText": ["Health care-associated infections (HAIs) are a significant public health problem worldwide, favoring multidrug-resistant (MDR) microorganisms. The SARS-CoV-2 infection was negatively associated with the increase in antimicrobial resistance, and the ESKAPE group had the most significant impact on HAIs. The study evaluated the bactericidal effect of a high concentration of O<sub>3</sub> gas on some reference and ESKAPE bacteria.", "Four standard strains and four clinical or environmental MDR strains were exposed to elevated ozone doses at different concentrations and times. Bacterial inactivation (growth and cultivability) was investigated using colony counts and resazurin as metabolic indicators. Scanning electron microscopy (SEM) was performed.", "The culture exposure to a high level of O<sub>3</sub> inhibited the growth of all bacterial strains tested with a statistically significant reduction in colony count compared to the control group. The cell viability of <i>S. aureus</i> (MRSA) (99.6%) and <i>P. aeruginosa</i> (XDR) (29.2%) was reduced considerably, and SEM showed damage to bacteria after O<sub>3</sub> treatment Conclusion: The impact of HAIs can be easily dampened by the widespread use of ozone in ICUs. This product usually degrades into molecular oxygen and has a low toxicity compared to other sanitization products. However, high doses of ozone were able to interfere with the growth of all strains studied, evidencing that ozone-based decontamination approaches may represent the future of hospital cleaning methods."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Technological Development in Health (CDTS), National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}], "LastName": "Rangel", "ForeName": "Karyne", "Initials": "K"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Department, National Institute for Quality Control in Health (INCQS), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}], "LastName": "Cabral", "ForeName": "Fellipe O", "Initials": "FO"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Technological Development in Health (CDTS), National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}], "LastName": "Lechuga", "ForeName": "Guilherme C", "Initials": "GC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Technological Development in Health (CDTS), National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Post-Graduation Program in Science and Biotechnology, Department of Molecular and Cellular Biology, Biology Institute, Federal Fluminense University, Niter\u00f3i 22040-036, Brazil."}], "LastName": "Carvalho", "ForeName": "Jo\u00e3o P R S", "Initials": "JPRS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Microbiology Department, National Institute for Quality Control in Health (INCQS), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}], "LastName": "Villas-B\u00f4as", "ForeName": "Maria H S", "Initials": "MHS"}, {"Identifier": ["0000-0001-9294-6597"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Cellular and Ultrastructure, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}], "LastName": "Midlej", "ForeName": "Victor", "Initials": "V"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center for Technological Development in Health (CDTS), National Institute of Science and Technology for Innovation in Neglected Population Diseases (INCT-IDPN), FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Laboratory of Epidemiology and Molecular Systematics (LESM), Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro 21040-900, Brazil."}, {"Identifier": [], "Affiliation": "Post-Graduation Program in Science and Biotechnology, Department of Molecular and Cellular Biology, Biology Institute, Federal Fluminense University, Niter\u00f3i 22040-036, Brazil."}], "LastName": "De-Simone", "ForeName": "Salvatore G", "Initials": "SG"}], "GrantList": [{"GrantID": "#467.488.2014-2; #3075732011; #3013322015-0", "Agency": "Brazilian Council for Scientific Research (CNPq)", "Country": ""}, {"GrantID": "$110.198-13; #202.841-2018", "Agency": "Carlos Chagas Filho Foundation for Research Support of the State of Rio de Janeiro (FAPERJ )", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Bacterial Agents"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Anti-Bacterial Agents"}, {"QualifierName": [], "DescriptorName": "Bacteria"}, {"QualifierName": ["microbiology"], "DescriptorName": "Cross Infection"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Ozone"}, {"QualifierName": [], "DescriptorName": "Pseudomonas aeruginosa"}, {"QualifierName": [], "DescriptorName": "SARS-CoV-2"}, {"QualifierName": [], "DescriptorName": "Staphylococcus aureus"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Allegranzi B., Bagheri Nejad S., Combescure C., Graafmans W., Attar H., Donaldson L., Pittet D. Burden of endemic health-care-associated infection in developing countries: Systematic review and meta-analysis. Lancet. 2011;337:228\u2013241. doi: 10.1016/S0140-6736(10)61458-4.", "ArticleIdList": ["10.1016/S0140-6736(10)61458-4", "21146207"]}, {"Citation": "ECDC  European Centre for Disease Prevention and Control Annual Epidemiological Report 2016- Healthcare-Associated Infections Acquired in Intensive Care Units. 2017.  [(accessed on 20 August 2021)].  Available online:  https://www.ecdc.Europa.eu/en/publications-data/healthcare-associated-infections-intensive-care-units-annualepidemiological-0."}, {"Citation": "Brasil  Boletim Seguran\u00e7a do Paciente e Qualidade em Servi\u00e7os de Sa\u00fade n\u00b0 16: Avalia\u00e7\u00e3o dos indicadores nacionais das Infec\u00e7\u00f5es Relacionadas \u00e0 Assist\u00eancia \u00e0 Sa\u00fade (IRAS) e Resist\u00eancia microbiana do ano de 2016.  [(accessed on 20 August 2021)];2017  Available online:  https://www20.Anvisa.gov.br/segurancadopaciente/index.php/publicacoes/item/boletim-seguranca-do-paciente-e-qualidade-em-servicos-de-saude-n-16-avaliacaodos-indicadores-nacionais-das-infeccoes-relacionadas-a-assistencia-a-saudeiras-e-resistenciamicrobiana-do-ano-de-2016."}, {"Citation": "Jenks J., Duse A., Wattal C., Zaidi A.K., Wertheim H.F., Sumpradit N., Vlieghe E., Hara G.L., Gould I.M., Goossens H., et al. Antibiotic resistance needs global solutions. Lancet Infect. Dis. 2014;14:550. doi: 10.1016/S1473-3099(14)70801-1.", "ArticleIdList": ["10.1016/S1473-3099(14)70801-1", "0"]}, {"Citation": "WHO (World Health Organization)   The Burden of Healthcare-Associated Infection Worldwide: A Summary. Vol. 3. World Health Organization; Lisboa, Portugal: 2011.  [(accessed on 20 August 2021)].  Available online:  http://www.who.int/gpsc/countrywork/summary20100430em.pdf."}, {"Citation": "Ali S., Birhane M., Bekele S., Kibru G., Teshager L., Yilma Y., Ahmed Y., Fentahun N., Assefa H., Gashaw M., et al. Healthcare-associated infection and its risk factors among patients admitted to a tertiary hospital in Ethiopia: A longitudinal study. Antimicrob. Resist. Infect. Control. 2018;7:2. doi: 10.1186/s13756-017-0298-5.", "ArticleIdList": ["10.1186/s13756-017-0298-5", "PMC5755436", "29312659"]}, {"Citation": "Umscheid C., Mitchell M.D., Doshi J.A., Agarwal R., Williams K., Brennan P.J. Estimating the proportion of healthcare-associated infections that are reasonably preventable and the associated mortality and costs. Infect. Control Hosp. Epidemiol. 2011;32:101\u2013114. doi: 10.1086/657912.", "ArticleIdList": ["10.1086/657912", "21460463"]}, {"Citation": "Gatt Y.E., Margalit H. Common adaptive strategies underlie within-host evolution of bacterial pathogens. Mol. Biol. Evol. 2021;38:1101\u20131121. doi: 10.1093/molbev/msaa278.", "ArticleIdList": ["10.1093/molbev/msaa278", "PMC7947768", "33118035"]}, {"Citation": "Santajit S., Indrawattana N. Mechanisms of antimicrobial resistance in ESKAPE pathogens. Biomed. Res. Int. 2016;2016:2475067. doi: 10.1155/2016/2475067.", "ArticleIdList": ["10.1155/2016/2475067", "PMC4871955", "27274985"]}, {"Citation": "Georgescu M., Gheorghe I., Curutiu C., Lazar V., Bleotu C., Chifiriuc M.C. Virulence and resistance features of Pseudomonas aeruginosa strains isolated from chronic leg ulcers. BMC Infect. Dis. 2016;16:92. doi: 10.1186/s12879-016-1396-3.", "ArticleIdList": ["10.1186/s12879-016-1396-3", "PMC4890939", "27169367"]}, {"Citation": "Coelho F., Coelho M., Diniz A., Vicente G., Vieira C. Velhos Problemas, novos desafios. Rev. Technol. Hospitalar. 2011;43:30\u201332."}, {"Citation": "Tadesse B.T., Ashley E.A., Ongarello S., Havumaki J., Wijegoonewardena M., Gonzalez I.J., Dittrich S. Antimicrobial resistance in Africa: A systematic review. BMC Infect. Dis. 2017;17:616. doi: 10.1186/s12879-017-2713-1.", "ArticleIdList": ["10.1186/s12879-017-2713-1", "PMC5594539", "28893183"]}, {"Citation": "Gajd\u00e1cs M., Albericio F. Antibiotic resistance: From the bench to patients. Antibiotics. 2019;8:129. doi: 10.3390/antibiotics8030129.", "ArticleIdList": ["10.3390/antibiotics8030129", "PMC6783868", "31461842"]}, {"Citation": "Boc\u00e9 M., Tass\u00e9 M., Mallet-Ladeira S., Pillet F., Da Silva C., Vicendo P., Lacroix P.G., Malfant I., Rols M.P. Effect of trans(NO, OH)-[RuFT(Cl)(OH)NO](PF(6)) ruthenium nitrosyl complex on methicillin-resistant Staphylococcus epidermidis. Sci. Rep. 2019;9:4867. doi: 10.1038/s41598-019-41222-0.", "ArticleIdList": ["10.1038/s41598-019-41222-0", "PMC6424994", "30890745"]}, {"Citation": "Andersen K.G., Rambaut A., Lipkin W.I., Holmes E.C., Garry R.F. The proximal origin of SARS-CoV-2. Nat. Med. 2020;26:450\u2013452. doi: 10.1038/s41591-020-0820-9.", "ArticleIdList": ["10.1038/s41591-020-0820-9", "PMC7095063", "32284615"]}, {"Citation": "Park S.E. Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19) Clin. Exp. Pediatr. 2020;63:119\u2013124. doi: 10.3345/cep.2020.00493.", "ArticleIdList": ["10.3345/cep.2020.00493", "PMC7170784", "32252141"]}, {"Citation": "Cucinotta D., Vanelli M. WHO Declares COVID-19 a Pandemic. Acta Biomed. 2020;91:157\u2013160. doi: 10.23750/abm.v91i1.9397.", "ArticleIdList": ["10.23750/abm.v91i1.9397", "PMC7569573", "32191675"]}, {"Citation": "Zhu N., Zhang D., Wang W., Li X., Yang B., Song J., Zhao X., Huang B., Shi W., Lu R., et al. China novel coronavirus investigating and research team. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 2020;382:727\u2013733. doi: 10.1056/NEJMoa2001017.", "ArticleIdList": ["10.1056/NEJMoa2001017", "PMC7092803", "31978945"]}, {"Citation": "Canto N.R., Ruiz-Garbajosa P. Co-resistance: An opportunity for the bacteria and resistance genes. Curr. Opin. Pharmacol. 2011;11:477\u2013485. doi: 10.1016/j.coph.2011.07.007.", "ArticleIdList": ["10.1016/j.coph.2011.07.007", "21840259"]}, {"Citation": "Clancy C.J., Nguyen M.H. Coroviruses disease 2019, superinfections, and antimicrobial development. What can we expect? Clin. Infect. Dis. 2020;71:2736\u20132743. doi: 10.1093/cid/ciaa524.", "ArticleIdList": ["10.1093/cid/ciaa524", "PMC7197597", "32361747"]}, {"Citation": "Bengoechea J.\u00c1., Bamford C.G.G. SARS-CoV-2, bacterial coinfections, and AMR: The deadly trio in COVID-19? EMBO Mol. Med. 2020;26:e12560. doi: 10.15252/emmm.202012560.", "ArticleIdList": ["10.15252/emmm.202012560", "PMC7283846", "32453917"]}, {"Citation": "Fu Y., Yang Q., Xu M., Kong H., Chen H., Fu Y., Yao Y., Zhou H., Zhou J. Secondary bacterial infections in critically ill patients with coronavirus disease 2019. Open Forum Infect. Dis. 2020;5:ofaa220. doi: 10.1093/ofid/ofaa220.", "ArticleIdList": ["10.1093/ofid/ofaa220", "PMC7313762", "32613024"]}, {"Citation": "Rawson T.M., Moore L.S.P., Zhu N., Ranganathan N., Skolimowska K., Gilchrist M., Satta G., Cooke G., Holmes A. Bacterial and fungal coinfection in individuals with coronavirus: A rapid review to support COVID-19 antimicrobial prescribing. Clin. Infect. Dis. 2020;71:2459\u20132468. doi: 10.1093/cid/ciaa530.", "ArticleIdList": ["10.1093/cid/ciaa530", "PMC7197596", "32358954"]}, {"Citation": "Chirumbolo S., Simonetti V., Franzini M., Valdenassi L., Bertossi D., Pandolfi S. Estimating coronavirus disease 2019 (COVID19)-caused deaths in hospitals and healthcare units: Do hospital-acquired infections play a role? Comments with a proposal. Infect. Control. Hosp. Epidemiol. 2021;19:1\u20132. doi: 10.1017/ice.2021.122.", "ArticleIdList": ["10.1017/ice.2021.122", "PMC8047388", "33736720"]}, {"Citation": "Lizioli A., Privitera G., Alliata E., Banfi E.M.A., Boselli L., Panceri M.L., Perna M.C., Porretta A.D., Santini M.G., Carreri V. Prevalence of nosocomial infections in Italy: Result from the Lombardy survey in 2000. J. Hosp. Infect. 2003;54:141\u2013148. doi: 10.1016/S0195-6701(03)00078-1.", "ArticleIdList": ["10.1016/S0195-6701(03)00078-1", "12818589"]}, {"Citation": "Nicastri E., Petrosillo N., Martini L., Larosa M., Gesu G.P., Ippolito G., INF-NOS Study Group Prevalence of nosocomial infections in 15 Italian hospitals: First point prevalence study for the INF-NOS project. Infection. 2003;71:10\u201315.", "ArticleIdList": ["15018467"]}, {"Citation": "Zotti C.M., Ioli G.M., Charrier L., Arditi G., Argentero P.A., Biglino A., Farina E.C., Ruggenini A.M., Reale R., Romagnoli S., et al. Hospital-acquired infections in Italy: A region wide prevalence study. J. Hosp. Infect. 2004;56:142\u2013149. doi: 10.1016/j.jhin.2003.10.001.", "ArticleIdList": ["10.1016/j.jhin.2003.10.001", "15019227"]}, {"Citation": "Mulani M.S., Kamble E.E., Kumkar S.N., Tawre M.S., Pardesi K.R. Emerging strategies to combat eskape pathogens in the era of antimicrobial resistance: A review. Front. Microbiol. 2019;10:539. doi: 10.3389/fmicb.2019.00539.", "ArticleIdList": ["10.3389/fmicb.2019.00539", "PMC6452778", "30988669"]}, {"Citation": "De Oliveira D.M.P., Forde B.M., Kidd T.J., Harris P.N.A., Schembri M.A., Beatson S.A., Paterson D.L., Walker M.J. Antimicrobial resistance in ESKAPE pathogens. Clin. Microbiol. Rev. 2020;33:e00181-19. doi: 10.1128/CMR.00181-19.", "ArticleIdList": ["10.1128/CMR.00181-19", "PMC7227449", "32404435"]}, {"Citation": "Munita J.M., Arias C.A. Mechanisms of antibiotic resistance. Microbiol. Spectr. 2016;4:10. doi: 10.1128/microbiolspec.VMBF-0016-2015.", "ArticleIdList": ["10.1128/microbiolspec.VMBF-0016-2015", "PMC4888801", "27227291"]}, {"Citation": "Miller W.R., Munita J.M., Arias C.A. Mechanisms of antibiotic resistance in enterococci. Expert. Rev. Anti. Infect. Ther. 2014;12:1221\u20131236. doi: 10.1586/14787210.2014.956092.", "ArticleIdList": ["10.1586/14787210.2014.956092", "PMC4433168", "25199988"]}, {"Citation": "WHO (World Health Organization)   Global Priority List of Antibiotic-Resistant Bacteria to Guide Research, Discovery, and Development of New Antibiotics. World Health Organization; Geneva, Switzerland: 2017.  [(accessed on 15 August 2021)].  Available online:  https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf."}, {"Citation": "Fernandes A.T., Fernandes M.O.V., Ribeiro Filho N., Graziano K.U., Gabrielloni M.C., Cavalcante N.J.F., Lacerda R.A. Infec\u00e7\u00e3o Hospitalar e Suas Interfaces na \u00c1rea da Sa\u00fade. 1st ed. Atheneu; S\u00e3o Paulo, Brazil: 2000. p. 1795."}, {"Citation": "Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pan drug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268\u2013281. doi: 10.1111/j.1469-0691.2011.03570.x.", "ArticleIdList": ["10.1111/j.1469-0691.2011.03570.x", "21793988"]}, {"Citation": "Oliveira A.C. Infec\u00e7\u00f5es Hospitalares, Epidemiologia, Preven\u00e7\u00e3o e Controle. 1st ed. Guanabara Koogan\u2014Grupo Gen; Rio de Janeiro, Brazil: 2005. p. 710."}, {"Citation": "Stephanie J.D. Controlling hospital-acquired infection: Focus on the role of the environment and new technologies for decontamination. Clin. Microbiol. Rev. 2014;27:665\u2013690. doi: 10.1128/CMR.00020-14.", "ArticleIdList": ["10.1128/CMR.00020-14", "PMC4187643", "25278571"]}, {"Citation": "Moccia G., Motta O., Pironti C., Proto A., Capunzo M., De Caro F. An alternative approach for the decontamination of hospital settings. J. Infect. Public Health. 2020;13:2038\u20132044. doi: 10.1016/j.jiph.2020.09.020.", "ArticleIdList": ["10.1016/j.jiph.2020.09.020", "PMC7577675", "33289645"]}, {"Citation": "Pironti C., Motta O., Proto A. Development of a new vapor phase methodology for textiles disinfection. Clean. Engin. Technol. 2021;4:100170. doi: 10.1016/j.clet.2021.100170.", "ArticleIdList": ["10.1016/j.clet.2021.100170"]}, {"Citation": "Bayarri B., Cruz-Alcalde A., L\u00f3pez-Vinent N., Mic\u00f3 M.M., Sans C.J. Can ozone inactivate SARS-CoV-2? A review of mechanisms and performance on viruses. J. Hazard. Mater. 2021;415:125658. doi: 10.1016/j.jhazmat.2021.125658.", "ArticleIdList": ["10.1016/j.jhazmat.2021.125658", "PMC7955572", "33752085"]}, {"Citation": "Nascente E.P., Chagas S.R., Pessoa A.V.C., Matos M.P.C., Andrade M.A., Pascoal L.M. Potencial antimicrobiano do oz\u00f4nio: Aplica\u00e7\u00f5es e perspectivas em medicina veterin\u00e1ria. Pubvet. 2019;13:130. doi: 10.31533/pubvet.v13n9a412.1-14.", "ArticleIdList": ["10.31533/pubvet.v13n9a412.1-14"]}, {"Citation": "Bocci V. Ozone: A New Medical Drug. 2nd ed. Springer; Berlin/Heidelberg, Germany: 2010. p. 336.", "ArticleIdList": ["10.1007/978-90-481-9234-2"]}, {"Citation": "Wickramanayake G.B., Sproul O.J. Ozone concentration and temperature effects on disinfection kinetics. Ozone Sci. Eng. 1988;10:123\u2013135. doi: 10.1080/01919518808552161.", "ArticleIdList": ["10.1080/01919518808552161"]}, {"Citation": "Wolf C., Von Gunten U., Kohn T. Kinetics of inactivation of waterborne enteric viruses by ozone. Environ. Sci. Technol. 2018;52:2170\u20132177. doi: 10.1021/acs.est.7b05111.", "ArticleIdList": ["10.1021/acs.est.7b05111", "29356522"]}, {"Citation": "Blanchard E.L., Lawrence J.D., Noble J.A., Xu M., Joo T., Ng N.L., Schmidt B.E., Santangelo P.J., Finn M.G.G. Enveloped virus inactivation on personal protective equipment by exposure to ozone. medRxiv. 2020 doi: 10.1101/2020.05.23.20111435.", "ArticleIdList": ["10.1101/2020.05.23.20111435"]}, {"Citation": "Dubuis M.E.E., Dumont-Leblond N., Lalibert\u2019e C., Veillette M., Turgeon N., Jean J., Duchaine C. Ozone efficacy for the control of airborne viruses: Bacteriophage and norovirus models. PLoS ONE. 2020;15:e0231164. doi: 10.1371/journal.pone.0231164.", "ArticleIdList": ["10.1371/journal.pone.0231164", "PMC7147755", "32275685"]}, {"Citation": "Davies A., Pottage T., Bennett A., Walker J. Gaseous and air decontamination technologies for Clostridium difficile in the healthcare environment. J. Hosp. Infect. 2011;77:199\u2013203. doi: 10.1016/j.jhin.2010.08.012.", "ArticleIdList": ["10.1016/j.jhin.2010.08.012", "21130521"]}, {"Citation": "Moat J., Cargill J., Shone J., Upton M. Application of a novel decontamination process using gaseous ozone. Canad. J. Microbiol. 2009;55:928\u2013933. doi: 10.1139/W09-046.", "ArticleIdList": ["10.1139/W09-046", "19898532"]}, {"Citation": "Pileti\u0107 K., Kova\u010d B., Per\u010di\u0107 M., \u017digon J., Brozni\u0107 D., Karleu\u0161a L., Blagojevi\u0107 S.L., Oder M., Gobin I. Disinfectin action of gaseous ozone on OXA-48-producing Klebsiella pneumoniae biofilm in vitro. Int. J. Environ. Res. Public Health. 2022;19:6177. doi: 10.3390/ijerph19106177.", "ArticleIdList": ["10.3390/ijerph19106177", "PMC9140702", "35627712"]}, {"Citation": "Sharma M., Hudson J.B. Ozone gas is an effective and practical antibacterial agent. Am. J. Infect. Control. 2008;36:559\u2013563. doi: 10.1016/j.ajic.2007.10.021.", "ArticleIdList": ["10.1016/j.ajic.2007.10.021", "18926308"]}, {"Citation": "Moccia G., De Caro F., Pironti C., Boccia G., Capunzo M., Borrelli A., Motta O. Development and improvement of an effective method for air and surfaces disinfection with ozone gas as a decontaminating agent. Medicina. 2020;56:578. doi: 10.3390/medicina56110578.", "ArticleIdList": ["10.3390/medicina56110578", "PMC7694113", "33143010"]}, {"Citation": "Rangel K., Cabral F.O., Lechuga G.C., Carvalho J.P.R.S.C., Villas-B\u00f4as M.H.S., Midlej V., De-Simone S.G. Detrimental effect of ozone on pathogenic bacteria. Microorganisms. 2022;10:40. doi: 10.3390/microorganisms10010040.", "ArticleIdList": ["10.3390/microorganisms10010040", "PMC8779011", "35056489"]}, {"Citation": "Fontes B., Heimbecker A.M.C., de Souza Brito G., Costa S.F., van der Heijden I.M., Levin A.S., Rasslan S. Effect of low-dose gaseous ozone on pathogenic bacteria. BMC Infect. Dis. 2012;12:358. doi: 10.1186/1471-2334-12-358.", "ArticleIdList": ["10.1186/1471-2334-12-358", "PMC3541223", "23249441"]}, {"Citation": "Merks P., Religioni U., Bilmin K., Bogusz J., Juszczyk G., Bara\u0144ska A., Kuthan R., Drelich E., Jakubowska M., \u015awieczkowski D., et al. Ozone disinfection of community pharmacies during the COVID-19 pandemic as a possible preventive measure for infection spread. Med. Pr. 2021;72:529\u2013534. doi: 10.13075/mp.5893.01091.", "ArticleIdList": ["10.13075/mp.5893.01091", "34140707"]}, {"Citation": "Franke G., Knobling B., Brill F.H., Becker B., Klupp E.M., Belmar Campos C., Pfefferle S., L\u00fctgehetmann M., Knobloch J.K. An automated room disinfection system using ozone is highly active against surrogates for SARS-CoV-2. J. Hosp. Infect. 2021;112:108\u2013113. doi: 10.1016/j.jhin.2021.04.007.", "ArticleIdList": ["10.1016/j.jhin.2021.04.007", "PMC8046700", "33864891"]}, {"Citation": "Percivalle E., Clerici M., Cassaniti I., Nepita E.V., Marchese P., Olivati D., Catelli C., Berri A., Baldanti F., Marone P., et al. SARS-CoV-2 viability on different surfaces after gaseous ozone treatment: A preliminary evaluation. J. Hosp. Infect. 2021;110:33\u201336. doi: 10.1016/j.jhin.2021.01.014.", "ArticleIdList": ["10.1016/j.jhin.2021.01.014", "PMC7842195", "33516798"]}, {"Citation": "Radvar S., Karkon-Shayan S., Motamed-Sanaye A., Majidi M., Hajebrahimi S., Taleschian-Tabrizi N., Pashazadeh F., Sahebkar A. Using ozone therapy as an option for treatment of COVID-19 Patients: A scoping review. Adv. Exp. Med. Biol. 2021;1327:151\u2013160. doi: 10.1007/978-3-030-71697-4_12.", "ArticleIdList": ["10.1007/978-3-030-71697-4_12", "34279836"]}, {"Citation": "Brodowska A.J., Nowak A., \u015amigielski K. Ozone in the food industry: Principles of ozone treatment, mechanisms of action, and applications: An overview. Crit. Rev. Food Sci. Nutr. 2018;58:2176\u20132201. doi: 10.1080/10408398.2017.1308313.", "ArticleIdList": ["10.1080/10408398.2017.1308313", "28394634"]}, {"Citation": "Feng L., Zhang K., Gao M., Shi C., Ge C., Qu D., Zhu J., Shi Y., Han J. Inactivation of Vibrio parahaemolyticus by aqueous ozone. J. Microbiol. Biotechnol. 2018;28:1233\u20131246. doi: 10.4014/jmb.1801.01056.", "ArticleIdList": ["10.4014/jmb.1801.01056", "29996623"]}, {"Citation": "Ersoy Z.G., Barisci S., Turkay O. Mechanisms of the Escherichia coli and Enterococcus faecalis inactivation by ozone. Food Sci. Technol. 2019;100:306\u2013313. doi: 10.1016/j.lwt.2018.10.095.", "ArticleIdList": ["10.1016/j.lwt.2018.10.095"]}, {"Citation": "Zhang Y.Q., Wu Q.P., Zhang J.M., Yang X.H. Effects of ozone on membrane permeability and ultrastructure in Pseudomonas aeruginosa. J. Appl. Microbiol. 2011;111:1006\u20131015. doi: 10.1111/j.1365-2672.2011.05113.x.", "ArticleIdList": ["10.1111/j.1365-2672.2011.05113.x", "21790913"]}, {"Citation": "Lall N., Henley-Smith C.J., Canha M.N., Oosthuizen C.B., Barrington D. Viability reagent presto blue in comparison with other available reagents utilized in cytotoxicity and antimicrobial assays. Int. J. Microbiol. 2013;2013:420601. doi: 10.1155/2013/420601.", "ArticleIdList": ["10.1155/2013/420601", "PMC3638707", "23653650"]}, {"Citation": "Riss T., Moravec R., Niles A. Development for cell viability and apoptosis for high-throughput screening. In: Chen T., editor. A Practical Guide to Assay Development and High-Throughput Screening in Drug Discovery. CRC Press; Boca Raton, FL, USA: 2010. pp. 109\u2013110."}, {"Citation": "Riss T., Moravec R.A., Niles A.L., Duellman S., Benink H.A., Worzella T.J., Minor L., Markossian S., Grossman A., Brimacombe K., et al. Cell Viability Assays. In: Sittampalam G., editor. The Assay Guidance Manual. Eli Lilly Co.; Indianapolis, IN, USA: National Center for Advancing Translational Sciences; Bethesda, MD, USA: 2016. pp. 10\u201312."}, {"Citation": "Pr\u00e4bst K., Engelhardt H., Ringgeler S., H\u00fcbner H. Basic colorimetric proliferation assays: MTT WST and resazurin. Methods Mol. Biol. 2017;1601:1\u201317. doi: 10.1007/978-1-4939-6960-9_1.", "ArticleIdList": ["10.1007/978-1-4939-6960-9_1", "28470513"]}, {"Citation": "Sousa C.S., Torres L.M., Azevedo M.P.F., Camargo T.C., Graziano K.U., Lacerda R.A., Turrini R.N.T. Sterilization with ozone in health care: An integrative literature review. Rev. Esc. Enfer. USP. 2011;45:1243\u20131249. doi: 10.1590/S0080-62342011000500030.", "ArticleIdList": ["10.1590/S0080-62342011000500030", "22031389"]}, {"Citation": "Rubio-Romero J.C., Pardo-Ferreira M.D.C., Torrecilla-Garc\u00eda J.A., Calero-Castro S. Disposable masks: Disinfection and sterilization for reuse, and non-certified manufacturing, in the face of shortages during the COVID-19 pandemic. Saf. Sci. 2020;129:104830. doi: 10.1016/j.ssci.2020.104830.", "ArticleIdList": ["10.1016/j.ssci.2020.104830", "PMC7218384", "32406406"]}, {"Citation": "EPA. Environmental Protection Agency  Integrated Science Assessment for Ozone and Related Photochemical Oxidant (Final Report, April 2020)  [(accessed on 15 August 2021)];2020  Available online:  https://cfpub.epa.gov/ncea/isa/recordisplay.cfm?deid=348522."}, {"Citation": "Blanco A., Ojembarrena F.B., Clavo B., Negro C. Ozone potential to fight against SAR-COV-2 pandemic: Facts and research needs. Environ. Sci. Pollut. Res. Int. 2021;28:16517\u201316531. doi: 10.1007/s11356-020-12036-9.", "ArticleIdList": ["10.1007/s11356-020-12036-9", "PMC7778500", "33389580"]}, {"Citation": "Grignani E., Mansi A., Cabella R., Castellano P., Tirabasso A., Sisto R., Spagnoli M., Fabrizi G., Frigerio F., Tranfo G. Safe and effective use of ozone as air and surface disinfectant in the conjuncture of COVID-19. Gases. 2021;1:19\u201332. doi: 10.3390/gases1010002.", "ArticleIdList": ["10.3390/gases1010002"]}, {"Citation": "Hudson J.B., Sharma M., Vimalanathan S. Development of a practical method for using ozone gas as a virus decontaminating agent. Ozone Sci. Eng. 2009;31:216\u2013223. doi: 10.1080/01919510902747969.", "ArticleIdList": ["10.1080/01919510902747969"]}, {"Citation": "McClurkin J.D., Maier D.E., Ileleji K.E. Half-life time of ozone as a function of air movement and conditions in a sealed container. J. Stored Prod. Res. 2013;55:41\u201347. doi: 10.1016/j.jspr.2013.07.006.", "ArticleIdList": ["10.1016/j.jspr.2013.07.006"]}, {"Citation": "Dennis R., Cashion A., Emanuel S., Hubbard D. Ozone gas: Scientific justification and practical guidelines for improvised disinfection using consumer-grade ozone generators and plastic storage boxes. J. Sci. Med. 2020;2:1\u201315. doi: 10.37714/josam.v2i1.35.", "ArticleIdList": ["10.37714/josam.v2i1.35"]}, {"Citation": "Tseng C., Li C. Inactivation of surface viruses by gaseous ozone. J. Environ. Health. 2008;70:56\u201363.", "ArticleIdList": ["18561570"]}, {"Citation": "Knobling B., Franke G., Klupp E.M., Belmar Campos C., Knobloch J.K. Evaluation of the effectiveness of two automated room decontamination devices under real-life conditions. Front. Public Health. 2021;9:618263. doi: 10.3389/fpubh.2021.618263.", "ArticleIdList": ["10.3389/fpubh.2021.618263", "PMC7940181", "33708756"]}, {"Citation": "Zoutman D., Shannon M., Mandel A. Effectiveness of a novel ozone-based system for the rapid high-level disinfection of health care spaces and surfaces. Am. J. Infect. Control. 2011;39:873\u2013879. doi: 10.1016/j.ajic.2011.01.012.", "ArticleIdList": ["10.1016/j.ajic.2011.01.012", "21546123"]}, {"Citation": "Xu Y., Ji J., Wu H., Pi F., Bla\u017eenovi\u0107 I., Zhang Y., Sun X. Untargeted GC-TOFMS-based cellular metabolism analysis to evaluate ozone degradation effect of deoxynivalenol. Toxicon. 2019;168:49\u201357. doi: 10.1016/j.toxicon.2019.06.022.", "ArticleIdList": ["10.1016/j.toxicon.2019.06.022", "31207350"]}, {"Citation": "He\u00df S., Gallert C. Sensitivity of antibiotic-resistant and antibiotic susceptible Escherichia coli, Enterococcus and Staphylococcus, strains against ozone. J. Water Health. 2015;13:1020\u20131028. doi: 10.2166/wh.2015.291.", "ArticleIdList": ["10.2166/wh.2015.291", "26608763"]}, {"Citation": "Schulz zur Wiesch P., Engelstadter J., Bonhoeffer S. Compensation of fitness costs and reversibility of antibiotic resistance mutations. Antimicrob. Agents Chemother. 2010;54:2085\u20132095. doi: 10.1128/AAC.01460-09.", "ArticleIdList": ["10.1128/AAC.01460-09", "PMC2863634", "20176903"]}, {"Citation": "Von Gunten U. Ozonation of drinking water: Part II. Disinfection and by-product formation in presence of bromide, iodide, or chlorine. Water Res. 2003;37:1469\u20131487. doi: 10.1016/S0043-1354(02)00458-X.", "ArticleIdList": ["10.1016/S0043-1354(02)00458-X", "12600375"]}, {"Citation": "Von Sonntag C., Von Gunten U. Chemistry of Ozone in Water and Wastewater Treatment from Basic Principles to Applications. IWA Publishing; London, UK: 2012. p. 306.", "ArticleIdList": ["10.2166/9781780400839"]}, {"Citation": "Casolari A. Microbial Death. In: Bazin M.J., Prosser J.I., editors. Physiological Models in Microbiology. Volume 2. CRC Press; Boca Raton, FL, USA: 1988. pp. 1\u201344."}, {"Citation": "Broadwater W.T., Hoehn R.C., King P.H. Sensitivity of three selected bacterial species to ozone. Appl. Microbiol. 1973;26:391\u2013393. doi: 10.1128/am.26.3.391-393.1973.", "ArticleIdList": ["10.1128/am.26.3.391-393.1973", "PMC379797", "4201643"]}, {"Citation": "Patil S., Valdramidis V.P., Karatzas K.A., Cullen P.J., Bourke P. Assessing the microbial oxidative stress mechanism of ozone treatment through the responses of Escherichia coli mutants. J. Appl. Microbiol. 2011;111:136\u2013144. doi: 10.1111/j.1365-2672.2011.05021.x.", "ArticleIdList": ["10.1111/j.1365-2672.2011.05021.x", "21457413"]}, {"Citation": "Xu P., Janex M.L., Savoye P., Cockx A., Lazarova V. Wastewater disinfection by ozone: Main parameters for process design. Water Res. 2002;36:1043\u20131055. doi: 10.1016/S0043-1354(01)00298-6.", "ArticleIdList": ["10.1016/S0043-1354(01)00298-6", "11848343"]}, {"Citation": "Patil S., Bourke P., Frias J.M., Tiwari B.K. Inactivation of Escherichia coli in orange juice using ozone. Inn. Food Sci. Emerg. Technol. 2009;10:551\u2013557. doi: 10.1016/j.ifset.2009.05.011.", "ArticleIdList": ["10.1016/j.ifset.2009.05.011"]}, {"Citation": "Pak G., Salcedo D.E., Lee H., Oh J., Maeng S.K., Song K.G., Hong S.W., Kim H.C., Chandran K., Kim S. Comparison of antibiotic resistance removal efficiencies using ozone disinfection under different pH and suspended solids and humic substance concentrations. Environ. Sci. Technol. 2016;50:7590\u20137600. doi: 10.1021/acs.est.6b01340.", "ArticleIdList": ["10.1021/acs.est.6b01340", "27389869"]}, {"Citation": "Adler M.G., Hill G.R. The kinetics and mechanism of hydroxide iron-catalyzed ozone decomposition in aqueous solutions. J. Am. Chem. Soc. 1950;72:1884\u20131886. doi: 10.1021/ja01161a007.", "ArticleIdList": ["10.1021/ja01161a007"]}, {"Citation": "Hoigne J., Bader H. Ozonation of water: Role of hydroxyl radicals as oxidizing intermediates. Science. 1975;190:782\u2013784. doi: 10.1126/science.190.4216.782.", "ArticleIdList": ["10.1126/science.190.4216.782"]}, {"Citation": "Kang S.W. Superoxide dismutase 2 gene and cancer risk: Evidence from an updated meta-analysis. Int. J. Clinic. Exp. Med. 2015;8:14647\u201314655.", "ArticleIdList": ["PMC4658836", "26628947"]}, {"Citation": "Imlay J.A. Cellular defenses against superoxide and hydrogen peroxide. Annu. Rev. Biochem. 2008;77:755\u2013776. doi: 10.1146/annurev.biochem.77.061606.161055.", "ArticleIdList": ["10.1146/annurev.biochem.77.061606.161055", "PMC3057177", "18173371"]}, {"Citation": "Pomposiello P.J., Demple B. Redox-operated genetic switches: The SoxR and OxyR transcription factors. Trends. Biotechnol. 2021;19:109\u2013114. doi: 10.1016/S0167-7799(00)01542-0.", "ArticleIdList": ["10.1016/S0167-7799(00)01542-0", "11179804"]}, {"Citation": "Greenberg J.T., Monach P., Chou J.H., Josephy P.D., Demple B. Positive control of a global antioxidant defense regulon activated by superoxide generating agents in Escherichia coli. Proc. Natl. Acad. Sci. USA. 1990;87:6181\u20136185. doi: 10.1073/pnas.87.16.6181.", "ArticleIdList": ["10.1073/pnas.87.16.6181", "PMC54496", "1696718"]}, {"Citation": "Delaney J.M. Requirement of the Escherichia coli dnaK gene for thermotolerance and protection against H2O2. J. Gen. Microbiol. 1990;136:2113\u20132118. doi: 10.1099/00221287-136-10-2113.", "ArticleIdList": ["10.1099/00221287-136-10-2113", "2269877"]}, {"Citation": "Rockabrand D., Arthur T., Korinek G., Livers K., Blum P. An essential role for the Escherichia coli DnaK protein in starvation-induced thermotolerance, H2O2 resistance, and reductive division. J. Bacteriol. 1995;177:3695\u20133703. doi: 10.1128/jb.177.13.3695-3703.1995.", "ArticleIdList": ["10.1128/jb.177.13.3695-3703.1995", "PMC177085", "7601833"]}, {"Citation": "Loewen P., Hu B., Strutinsky J., Sparling R. Regulation in the rpoS regulon of Escherichia coli. Can. J. Microbiol. 1998;44:707\u2013717. doi: 10.1139/w98-069.", "ArticleIdList": ["10.1139/w98-069", "9830102"]}, {"Citation": "Chaffin D.O., Taylor D., Skerrett S.J., Rubens C.E. Changes in the Staphylococcus aureus transcriptome during early adaptation to the lung. PLoS ONE. 2012;7:e41329. doi: 10.1371/journal.pone.0041329.", "ArticleIdList": ["10.1371/journal.pone.0041329", "PMC3410880", "22876285"]}, {"Citation": "Hamelin C., Chung Y.S. Optimal conditions for mutagenesis by ozone in Escherichia coli K12. Mutat. Res. 1974;24:271\u2013279. doi: 10.1016/0027-5107(74)90175-4.", "ArticleIdList": ["10.1016/0027-5107(74)90175-4", "4606874"]}, {"Citation": "Hamelin C., Sarhan F., Chung Y.S. Ozone-induced DNA degradation in different DNA polymerase I mutants of Escherichia coli K12. Biochem. Biophys. Res. Commun. 1977;77:220\u2013224. doi: 10.1016/S0006-291X(77)80185-X.", "ArticleIdList": ["10.1016/S0006-291X(77)80185-X", "329840"]}, {"Citation": "Hamelin C., Sarhan F., Chung Y.S. Induction of deoxyribonucleic acid degradation in Escherichia coli by ozone. Experientia. 1978;34:1578\u20131579. doi: 10.1007/BF02034684.", "ArticleIdList": ["10.1007/BF02034684", "365568"]}, {"Citation": "Dodd M.C. Potential impacts of disinfection processes on eliminating and deactivating antibiotic resistance genes during water and wastewater treatment. J. Environ. Moni. 2012;14:1754\u20131771. doi: 10.1039/c2em00006g.", "ArticleIdList": ["10.1039/c2em00006g", "22572858"]}, {"Citation": "Scott D.B.M., Lesher E.C. Effect of ozone on survival and permeability of Escherichia coli. J. Bacteriol. 1963;85:567\u2013576. doi: 10.1128/jb.85.3.567-576.1963.", "ArticleIdList": ["10.1128/jb.85.3.567-576.1963", "PMC278184", "14174901"]}, {"Citation": "Hunt N.K., Mari\u00f1as B.J. Inactivation of Escherichia coli with ozone: Chemical and inactivation kinetics. Water Res. 1999;33:263\u2013264. doi: 10.1016/S0043-1354(99)00115-3.", "ArticleIdList": ["10.1016/S0043-1354(99)00115-3"]}, {"Citation": "Han L., Patil S., Boehm D., Milosavljevi\u0107 V., Cullen P.J., Bourke P. Mechanisms of inactivation by high-voltage atmospheric cold plasma differ for Escherichia coli and Staphylococcus aureus. Appl. Environ. Microbiol. 2016;82:450\u2013458. doi: 10.1128/AEM.02660-15.", "ArticleIdList": ["10.1128/AEM.02660-15", "PMC4711144", "26519396"]}, {"Citation": "Yu W., Zhang D., Graham N.J.D. Membrane fouling by extracellular polymeric substances after ozone pre-treatment: Variation of nano-particle size. Water Res. 2017;120:146\u2013155. doi: 10.1016/j.watres.2017.04.080.", "ArticleIdList": ["10.1016/j.watres.2017.04.080", "28482235"]}, {"Citation": "Halder S., Yadav K.K., Sarkar R., Mukherjee S., Saha P., Haldar S., Karmakar S., Sen T. Alteration of Zeta potential and membrane permeability in bacteria: A study with cationic agents. Springerplus. 2015;4:672\u2013686. doi: 10.1186/s40064-015-1476-7.", "ArticleIdList": ["10.1186/s40064-015-1476-7", "PMC4633473", "26558175"]}, {"Citation": "Nagayoshi M., Kitamura C., Fukuizumi T., Nishihara T., Terashita M. Antimicrobial effect of ozonated water on bacteria invading dentinal tubules. J. Endod. 2004;30:778\u2013781. doi: 10.1097/00004770-200411000-00007.", "ArticleIdList": ["10.1097/00004770-200411000-00007", "15505509"]}, {"Citation": "Russell A.D. Similarities and differences in the responses of microorganisms to biocides. J. Antimicrob. Chemother. 2003;52:750\u2013763. doi: 10.1093/jac/dkg422.", "ArticleIdList": ["10.1093/jac/dkg422", "14519671"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "5", "Day": "20"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "6", "Day": "15"}, {"Year": "2022", "Month": "7", "Day": "9", "Hour": "1", "Minute": "18"}, {"Year": "2022", "Month": "7", "Day": "10", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "7", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "6", "Day": "22"}], "PublicationStatus": "epublish", "ArticleIdList": ["35807244", "PMC9268618", "10.3390/molecules27133998", "molecules27133998"]}}], "PubmedBookArticle": []}